Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals Inc. | 38 | 1 | 2 | 0 | €968.80 | €1,006.8 | 3.922% |
Eli Lilly Corp. | 52 | 0 | 6 | 0 | €827.90 | €788.80 | -4.723% |
Vertex Pharmaceuticals Inc. | 48 | 2 | 4 | 0 | €444.60 | €428.60 | -3.599% |
Medpace Holdings Inc | 11 | 0 | 2 | 0 | €366.00 | €419.64 | 14.655% |
Madrigal Pharmaceuticals inc. | 3 | 0 | 0 | 0 | €258.70 | €315.00 | 21.763% |
Amgen Inc. | 26 | 0 | 1 | 0 | €280.60 | €297.31 | 5.956% |
Biogen Inc. | 50 | 1 | 4 | 0 | €212.60 | €293.22 | 37.923% |
United Therapeutics | 21 | 0 | 3 | 0 | €275.70 | €288.66 | 4.701% |
Alnylam Pharmace. | 36 | 0 | 0 | 0 | €150.00 | €236.30 | 57.532% |
Zoetis Inc. A | 23 | 1 | 0 | 0 | €157.94 | €200.06 | 26.667% |
Krystal Biotech | 18 | 0 | 1 | 0 | €167.00 | €180.00 | 7.784% |
AbbVie Inc. | 23 | 0 | 2 | 0 | €157.42 | €174.43 | 10.808% |
Neurocrine Bioscience | 32 | 0 | 3 | 0 | €126.30 | €140.87 | 11.534% |
Sarepta Therapeutics | 1 | 0 | 0 | 0 | €115.40 | €130.00 | 12.652% |
Merck & Co. Inc. | 30 | 1 | 2 | 0 | €119.00 | €124.97 | 5.019% |
Abbott Laboratories | 18 | 0 | 2 | 0 | €96.68 | €116.48 | 20.480% |